[
    {
        "file_name": "ArrayBioPharmaInc.-LICENSE,DEVELOPMENTANDCOMMERCIALIZATIONAGREEMENT.txt",
        "perturbation": [
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "All packaging materials, labels and Marketing Materials for the Products shall display the Product Trademarks in katakana or in other applicable language and no other product-specific trademarks or branding.",
                "changed_text": "Packaging materials, labels and Marketing Materials for the Products may display trademarks in any language. There are no restrictions on product-specific trademarks or branding.",
                "explanation": "This removes the required trademark to be on the packaging, enabling products to be distributed without the appropriate branding that allows consumers to know what product they are using, contradicting consumer protection laws related to proper product labeling and identification and making it a non-compliant contract.",
                "contradicted_law": "Consumer protection laws related to product labeling and identification, Trademark regulations.",
                "location": "Section 12.1(a)"
            },
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "(c)  Marketing Materials. Marketing, advertising and promotional materials (“Marketing Materials”) concerning the Products for use in the Ono Territory, as well as training manuals and education and communication materials (“Educational Materials”) for sales representatives in the Ono Territory shall be developed and prepared by Ono, at its own expense. Array shall provide reasonable assistance to Ono in connection with the foregoing, including supplying to Ono representative forms of Marketing Materials, training manuals and Educational Materials for the Product used by Array in the United States, France, Germany, Italy, Spain and the United Kingdom, which Ono, its Affiliates and Sublicensees may adapt for use in the Ono Territory. Any Marketing Materials, training manuals and/or Educational Materials developed and used by Ono, its Affiliates and Sublicensees for the Product in the Ono Territory shall be consistent with the Marketing Approval in the applicable country and with the reasonable trademark guidelines for use of the Binimetinib Product Trademark and Encorafenib Product Trademark agreed upon by the JCC, and shall comply with all applicable Laws, rules and regulations.",
                "changed_text": "(c) Marketing Materials. Marketing, advertising and promotional materials (“Marketing Materials”) concerning the Products for use in the Ono Territory, as well as training manuals and education and communication materials (“Educational Materials”) for sales representatives in the Ono Territory shall be developed and prepared by Ono, at its own expense. Ono, its Affiliates and Sublicensees will use the materials and manuals to comply with laws, rules and regulations.",
                "explanation": "Removal of the requirement for consistency with 'Marketing Approval', 'reasonable trademark guidelines', weakening the link between the promotional content and regulatory requirements. This increases legal risk, enabling misleading or unapproved marketing content, violating consumer laws concerning accurate advertising and promoting safety.",
                "contradicted_law": "Regulations concerning pharmaceutical marketing (e.g., advertising standards, FDA guidelines on promotion), consumer protection laws related to accurate advertising and safety promotion.",
                "location": "Section 5.1"
            },
            {
                "type": "Omissions - Omission Legal Contradiction",
                "original_text": "Any notice required or permitted under this Agreement shall be in writing in the English language, and (a) delivered personally, (b) sent by air mail or express courier service providing evidence of receipt, postage pre-paid where applicable, or (c) by electronic transmission or facsimile (complete transmission confirmed and a copy promptly sent by another permissible method of providing notice described in paragraph (a) or (b) above), to the following addresses of the Parties (or such other address for a Party as may be specified by like notice):",
                "changed_text": "Any notice required or permitted under this Agreement may be delivered in any form or medium. All notification requirements are entirely optional and at the sole discretion of the involved parties.",
                "explanation": "The omission of formally documented notification introduces legal risk by removing legally sound means of communication. This could lead to disputes with the other party. Furthermore, the law mandates how agreements must be followed/informed (e.g., certified mail).",
                "contradicted_law": "Contract law regarding notification; statutes requiring formal notification procedures.",
                "location": "Section 18.8"
            }
        ]
    }
]